04/16/2024 3:30 PM | Akero Therapeutics (Filer)
| Form PRE 14A | |
04/03/2024 5:55 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:17 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024 3:31 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 3:42 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:42 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:43 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/15/2024 3:44 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:45 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 9:08 AM | Akero Therapeutics (Subject) GENERAL ATLANTIC, L.P. (Filed by)
| Form SC 13G | |
03/06/2024 7:13 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:14 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:25 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:16 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
03/05/2024 4:16 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:30 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 6:55 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 3:42 PM | Akero Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024 6:30 AM | Akero Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 6:15 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 1:19 PM | Akero Therapeutics (Subject) PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:06 AM | Akero Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024 8:40 PM | Akero Therapeutics (Subject) Avidity Partners Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024 5:30 PM | Akero Therapeutics (Subject) ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 10:31 AM | Akero Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/07/2024 6:23 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Akero Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024 8:36 AM | Akero Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/29/2023 7:30 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 5:07 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 7:49 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:37 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:39 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:40 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:29 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 6:08 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 3:43 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:43 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:35 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:38 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:26 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 7:59 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 |
12/11/2023 8:06 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 7:37 AM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:30 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 4:37 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 6:33 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023 6:15 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 7:04 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 7:33 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 7:41 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 5:17 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 5:21 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2023 7:28 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:30 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:31 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:31 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:36 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 5:48 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:04 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:04 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 8:02 PM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023 5:09 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 3:13 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 6:52 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 7:44 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 12:07 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023 6:12 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 5:00 PM | Akero Therapeutics (Issuer) Xu Yuan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:52 PM | Akero Therapeutics (Issuer) Heyman Tomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:55 PM | Akero Therapeutics (Issuer) Henderson Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:58 PM | Akero Therapeutics (Issuer) Judy Chou (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:39 PM | Akero Therapeutics (Issuer) Iwicki Mark T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:48 PM | Akero Therapeutics (Issuer) Harrison Seth Loring (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:48 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 4:29 PM | Akero Therapeutics (Subject) Rolph Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023 3:02 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 7:06 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 4:20 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:54 PM | Akero Therapeutics (Issuer) Heyman Tomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:46 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:47 PM | Akero Therapeutics (Issuer) Henderson Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:00 PM | Akero Therapeutics (Subject) Heyman Tomas J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 4:41 PM | Akero Therapeutics (Subject) Henderson Jane (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 3:22 PM | Akero Therapeutics (Subject) Rolph Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 8:38 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:41 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:29 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:35 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:35 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:26 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4/A | |
06/05/2023 5:23 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 |
06/05/2023 7:05 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 8:55 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023 6:19 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2023 7:28 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |